A recent Australian Equity Strategy note from UBS highlights key shifts in the ASX 200. Traditionally viewed as a ‘boring ...

Opthea (ASX:OPT) has announced that its lead drug candidate sozinibercept has failed to meet primary endpoints in a phase 3 trial, raising serious concerns about the company’s future viability and its ...

Helia (ASX:HLI) has announced it is likely to lose a cornerstone contract with the Commonwealth Bank of Australia, following CBA’s decision to enter exclusive negotiations with an alternative provider ...

Turkey’s Capital Markets Board has imposed a sweeping ban on short selling and loosened share buyback restrictions in an effort to stabilise markets following a sharp sell-off triggered by political ...

James Hardie shares have fallen sharply after announcing a US$8.8bn (A$14bn) cash-and-scrip deal to acquire US-based outdoor building products maker AZEK Company (NYSE:AZEK). AZEK ...